The Use of Nasal Phenylephrine in Infants With Bronchiolitis

NCT ID: NCT00373802

Last Updated: 2009-01-12

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: PHASE2
• Total Enrollment: 50 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2005-01-31
• Study Completion Date: 2005-06-30

Brief Summary

Drops of either saline or phenylephrine are placed in the nose of infants less than 12 months of age to determine if it helps them to breathe easier.

Conditions

Bronchiolitis

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: TREATMENT
• Blinding Strategy: DOUBLE

Interventions

Phenylephrine

Intervention Type: DRUG

Eligibility Criteria

Inclusion Criteria

• Age 4 weeks to 12 months; admitting diagnosis of bronchiolitis; admitted to hospital's bronchiolitis pathway, admitted during weekdays, need for nasal suctioning.

Exclusion Criteria

• Congenital heart disease, history of hypertension, previous wheezing, prior use of inhaled corticosteroids, gestational age at birth of <34 weeks.

• Minimum Eligible Age: 4 Weeks
• Maximum Eligible Age: 12 Months
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Akron Children's Hospital

OTHER

Sponsor Role: lead

Responsible Party

Akron Children's Hospital

Principal Investigators

Rachel Konda-Sundheim, MD, MD

Role: PRINCIPAL_INVESTIGATOR

Children's Hospital Medical Center of Akron

Other Identifiers

NASAL #9579

Identifier Type: -

Identifier Source: org_study_id